HHealth Read More Scientists Race to Test Treatments as Ebola Outbreak WidensJune 13, 2026 In a hastily assembled Ebola treatment center in Rwampara, Democratic Republic of Congo, Dr. Papys Lame and his…
HHealth care Read More TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 TrialJune 10, 2026 TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
BBusiness Read More China’s Rise in Drug Development Looms Over U.S.May 31, 2026 For decades, an annual gathering of oncologists has featured drug trials that were run mainly at American and…
NNutrition Read More The Supplement That Science Says Could Make the World Less AngryMay 28, 2026 If you found out a supplement existed that could lower aggression, you would probably think it was something…
NNutrition Read More Industry and regulators signal a smarter, collaborative era for supplement oversightMay 27, 2026 While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
HHealth Read More F.D.A. Grants Early Access to Promising Drug for Pancreatic CancerMay 1, 2026 The Food and Drug Administration said on Friday that it would permit some patients with deadly pancreatic cancer…
BBusiness Read More FDA testing speedier drug development with real-time clinical trialsApril 29, 2026 WASHINGTON — The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting…
HHealth Read More 6 Common Medications That May Decrease Dementia RiskApril 23, 2026 Getting your annual flu shot may come with a significant side benefit: helping to protect you from dementia.…
HHealth Read More Multicentre gene therapy for OTOF-related deafness followed up to 2.5 yearsApril 22, 2026 Yasunaga, S. et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form…
AArtificial intelligence Read More Race for AI-developed drugs heats up: Wegovy-maker Novo Nordisk ties up with OpenAI after rival Eli Lilly seals dealApril 15, 2026 Danish drugmaker Novo Nordisk on Tuesday announced that it is collaborating with ChatGPT’s parent company, OpenAI, to bring…
HHealth Read More Stopping Ozempic? New study reveals surprising weight regain results after GLP-1sMarch 20, 2026 With millions of people using injectable GLP-1 medications like Ozempic, Wegovy or Zepbound, many may wonder what happens…
HHealth Read More ‘They told me 2 to 3 years’March 17, 2026 Every two weeks, a camper parked in a small lot one mile from the Duke Cancer Center becomes…